InvestSMART

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Announcements

Current share price for PAR : $0.240 0.045 (15.79%)+

ASX company news and announcements for Paradigm Biopharmaceuticals Limited (PAR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Paradigm Biopharmaceuticals Limited (PAR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Paradigm Biopharmaceuticals Limited (PAR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Paradigm Biopharmaceuticals Limited (PAR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$146 Application for quotation of securities - PAR 20 May 2024 4:03PM $0.260 $0.240 fallen by 7.69%
$146 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 9:54AM $0.255 $0.240 fallen by 5.88%
$146 Notification of cessation of securities - PAR 26 Apr 2024 4:46PM $0.270 $0.240 fallen by 11.11%
$146 Type D Response Submitted and Received by the US FDA 19 Apr 2024 8:36AM $0.285 $0.240 fallen by 15.79%
$146 Notification of cessation of securities - PAR 5 Apr 2024 7:49PM $0.330 $0.240 fallen by 27.27%
$146 PAR to present at NWR Healthcare Conference 20 Mar 2024 2:45PM $0.368 $0.240 fallen by 34.69%
$146 Change of Director's Interest Notice 8 Mar 2024 1:18PM $0.395 $0.240 fallen by 39.24%
$146 Change of Director's Interest Notice 8 Mar 2024 1:17PM $0.395 $0.240 fallen by 39.24%
$146 Final Director's Interest Notice 6 Mar 2024 9:27AM $0.360 $0.240 fallen by 33.33%
$146 Initial Director's Interest Notice 4 Mar 2024 11:20AM $0.350 $0.240 fallen by 31.43%
$146 Paradigm Board Changes 4 Mar 2024 9:14AM $0.335 $0.240 fallen by 28.36%
$146 Notification regarding unquoted securities - PAR 29 Feb 2024 10:22AM $0.340 $0.240 fallen by 29.41%
$146 PAR Employee Performance Rights Plan Issue 29 Feb 2024 10:17AM $0.340 $0.240 fallen by 29.41%
$146 Half Yearly Report and Accounts 28 Feb 2024 12:15PM $0.348 $0.240 fallen by 30.94%
$146 Notification regarding unquoted securities - PAR 13 Feb 2024 1:21PM $0.355 $0.240 fallen by 32.39%
$146 Proposed issue of securities - PAR 12 Feb 2024 8:26AM $0.345 $0.240 fallen by 30.43%
$146 PAR Appoints Business Development Consultant 9 Feb 2024 4:45PM $0.345 $0.240 fallen by 30.43%
$146 Primary Endpoint Achieved in Phase 2 MPS VI Trial 9 Feb 2024 9:04AM $0.355 $0.240 fallen by 32.39%
$146 Paradigm Receives $7.36m R&D Tax Incentive Refund 7 Feb 2024 9:14AM $0.320 $0.240 fallen by 25%
$146 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 8:48AM $0.375 $0.240 fallen by 36%
$146 Notification of cessation of securities - PAR 30 Jan 2024 5:24PM $0.375 $0.240 fallen by 36%
$146 Application for quotation of securities - PAR 30 Jan 2024 5:22PM $0.375 $0.240 fallen by 36%
$146 PAR Selected for Major OA Conference Presentations 30 Jan 2024 9:12AM $0.405 $0.240 fallen by 40.74%
$146 Notice of release of escrowed securities 15 Jan 2024 6:46PM $0.400 $0.240 fallen by 40%
$146 Change in substantial holding 6 Dec 2023 5:08PM $0.395 $0.240 fallen by 39.24%

176 - 200 of 729 results

Page 8 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.